{"date":"2025-06-27","count":55,"source":"公開資訊觀測站（MOPS）","attribution":"引用請註明：Drugnews 事實帳本（https://drugnews.com.tw/filings/）與公開資訊觀測站原始公告","records":[{"id":"tw-7607-2025-06-27-1959-1n1y3kt","company_id":"7607","company":"通用幹細胞*","market":"興櫃","industry":"生技醫療","date":"2025-06-27","time":"19:59:32","subject":"公告本公司董事長續任","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：通用幹細胞*（7607），2025-06-27 19:59，「公告本公司董事長續任」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7607-2025-06-27-1955-k1qdeo","company_id":"7607","company":"通用幹細胞*","market":"興櫃","industry":"生技醫療","date":"2025-06-27","time":"19:55:23","subject":"公告本公司第二屆審計委員會委員名單","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：通用幹細胞*（7607），2025-06-27 19:55，「公告本公司第二屆審計委員會委員名單」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4745-2025-06-27-1939-pd8o5l","company_id":"4745","company":"合富-KY","market":"上櫃","industry":"生技醫療","date":"2025-06-27","time":"19:39:44","subject":"代子公司合富中國公告累計取得理財產品達公告標準","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：合富-KY（4745），2025-06-27 19:39，「代子公司合富中國公告累計取得理財產品達公告標準」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4745-2025-06-27-1939-102v9ph","company_id":"4745","company":"合富-KY","market":"上櫃","industry":"生技醫療","date":"2025-06-27","time":"19:39:30","subject":"代子公司合富中國公告累計處分理財產品達公告標準","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：合富-KY（4745），2025-06-27 19:39，「代子公司合富中國公告累計處分理財產品達公告標準」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-3205-2025-06-27-1923-1rmi4u2","company_id":"3205","company":"佰研","market":"上櫃","industry":"生技醫療","date":"2025-06-27","time":"19:23:58","subject":"本公司對進滿投資股份有限公司、進富投資股份有限公司、璽富投資股份有限公司、楊清宗及魏碧素等五人公開收購本公司普通股股份之審議委員會結果","clause":"第38款","fact_date":"2025-06-27","cite_as":"公開資訊觀測站重大訊息：佰研（3205），2025-06-27 19:23，「本公司對進滿投資股份有限公司、進富投資股份有限公司、璽富投資股份有限公司、楊清宗及魏碧素等五人公開收購本公司普通股股份之」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6461-2025-06-27-1804-vqkii","company_id":"6461","company":"益得","market":"上櫃","industry":"生技醫療","date":"2025-06-27","time":"18:04:57","subject":"公告本公司註銷限制員工權利新股減資變更登記完成","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：益得（6461），2025-06-27 18:04，「公告本公司註銷限制員工權利新股減資變更登記完成」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6844-2025-06-27-1757-5rh607","company_id":"6844","company":"諾貝兒","market":"上櫃","industry":"生技醫療","date":"2025-06-27","time":"17:57:30","subject":"公告本公司董事會決議解除經理人競業禁止之限制","clause":"第21款","fact_date":"2025-06-27","cite_as":"公開資訊觀測站重大訊息：諾貝兒（6844），2025-06-27 17:57，「公告本公司董事會決議解除經理人競業禁止之限制」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6844-2025-06-27-1756-100z4xn","company_id":"6844","company":"諾貝兒","market":"上櫃","industry":"生技醫療","date":"2025-06-27","time":"17:56:53","subject":"公告本公司策略長及重要營運主管任命案","clause":"第8款","fact_date":"2025-06-27","cite_as":"公開資訊觀測站重大訊息：諾貝兒（6844），2025-06-27 17:56，「公告本公司策略長及重要營運主管任命案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6844-2025-06-27-1756-1ifbulk","company_id":"6844","company":"諾貝兒","market":"上櫃","industry":"生技醫療","date":"2025-06-27","time":"17:56:36","subject":"公告本公司董事會推選副董事長","clause":"第6款","fact_date":"2025-06-27","cite_as":"公開資訊觀測站重大訊息：諾貝兒（6844），2025-06-27 17:56，「公告本公司董事會推選副董事長」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6844-2025-06-27-1756-58zfmu","company_id":"6844","company":"諾貝兒","market":"上櫃","industry":"生技醫療","date":"2025-06-27","time":"17:56:22","subject":"公告本公司總經理異動案","clause":"第6款","fact_date":"2025-06-27","cite_as":"公開資訊觀測站重大訊息：諾貝兒（6844），2025-06-27 17:56，「公告本公司總經理異動案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6589-2025-06-27-1735-p9mhil","company_id":"6589","company":"台康生技","market":"上市","industry":"生技醫療","date":"2025-06-27","time":"17:35:25","subject":"本公司董事會委任第二屆公司治理委員會委員","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：台康生技（6589），2025-06-27 17:35，「本公司董事會委任第二屆公司治理委員會委員」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6589-2025-06-27-1732-a83305","company_id":"6589","company":"台康生技","market":"上市","industry":"生技醫療","date":"2025-06-27","time":"17:32:07","subject":"本公司董事會委任第四屆薪資報酬委員會委員","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：台康生技（6589），2025-06-27 17:32，「本公司董事會委任第四屆薪資報酬委員會委員」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6919-2025-06-27-1730-1elk5w0","company_id":"6919","company":"康霈*","market":"上市","industry":"生技醫療","date":"2025-06-27","time":"17:30:32","subject":"本公司新藥CBL-514注射劑用於減少腹部皮下脂肪之多國多中心樞紐三期臨床試驗申請，今日已完成美國FDA送件","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：康霈*（6919），2025-06-27 17:30，「本公司新藥CBL-514注射劑用於減少腹部皮下脂肪之多國多中心樞紐三期臨床試驗申請，今日已完成美國FDA送件」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6589-2025-06-27-1730-2ahq6y","company_id":"6589","company":"台康生技","market":"上市","industry":"生技醫療","date":"2025-06-27","time":"17:30:04","subject":"本公司審計委員會委員異動","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：台康生技（6589），2025-06-27 17:30，「本公司審計委員會委員異動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6589-2025-06-27-1728-1gajc8e","company_id":"6589","company":"台康生技","market":"上市","industry":"生技醫療","date":"2025-06-27","time":"17:28:34","subject":"本公司董事會選任董事長","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：台康生技（6589），2025-06-27 17:28，「本公司董事會選任董事長」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6589-2025-06-27-1726-mnpnf","company_id":"6589","company":"台康生技","market":"上市","industry":"生技醫療","date":"2025-06-27","time":"17:26:46","subject":"本公司股東常會決議解除董事及其代表人競業禁止之限制","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：台康生技（6589），2025-06-27 17:26，「本公司股東常會決議解除董事及其代表人競業禁止之限制」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6917-2025-06-27-1725-9d7s9s","company_id":"6917","company":"竟天","market":"興櫃","industry":"生技醫療","date":"2025-06-27","time":"17:25:27","subject":"本公司研發主管異動","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：竟天（6917），2025-06-27 17:25，「本公司研發主管異動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6589-2025-06-27-1723-11qx82t","company_id":"6589","company":"台康生技","market":"上市","industry":"生技醫療","date":"2025-06-27","time":"17:23:57","subject":"本公司114年股東常會改選董事","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：台康生技（6589），2025-06-27 17:23，「本公司114年股東常會改選董事」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1786-2025-06-27-1718-ds864w","company_id":"1786","company":"科妍","market":"上市","industry":"生技醫療","date":"2025-06-27","time":"17:18:30","subject":"公告本公司114年股東常會重要決議事項","clause":"第18款","fact_date":"2025-06-27","cite_as":"公開資訊觀測站重大訊息：科妍（1786），2025-06-27 17:18，「公告本公司114年股東常會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6589-2025-06-27-1712-omoyuw","company_id":"6589","company":"台康生技","market":"上市","industry":"生技醫療","date":"2025-06-27","time":"17:12:34","subject":"本公司股東常會重要決議","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：台康生技（6589），2025-06-27 17:12，「本公司股東常會重要決議」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1731-2025-06-27-1654-1kbupvl","company_id":"1731","company":"美吾華","market":"上市","industry":"生技醫療","date":"2025-06-27","time":"16:54:19","subject":"公告修正本公司113年度股東會年報部分內容","clause":"第51款","fact_date":"2025-06-27","cite_as":"公開資訊觀測站重大訊息：美吾華（1731），2025-06-27 16:54，「公告修正本公司113年度股東會年報部分內容」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6936-2025-06-27-1641-v1gwxu","company_id":"6936","company":"永鴻生技","market":"上市","industry":"生技醫療","date":"2025-06-27","time":"16:41:53","subject":"公告本公司調整現金股利配息率","clause":"第14款","fact_date":"2025-06-27","cite_as":"公開資訊觀測站重大訊息：永鴻生技（6936），2025-06-27 16:41，「公告本公司調整現金股利配息率」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6936-2025-06-27-1641-4yzujo","company_id":"6936","company":"永鴻生技","market":"上市","industry":"生技醫療","date":"2025-06-27","time":"16:41:12","subject":"公告本公司訂定除息基準日相關事宜","clause":"第14款","fact_date":"2025-06-27","cite_as":"公開資訊觀測站重大訊息：永鴻生技（6936），2025-06-27 16:41，「公告本公司訂定除息基準日相關事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6936-2025-06-27-1640-ds864w","company_id":"6936","company":"永鴻生技","market":"上市","industry":"生技醫療","date":"2025-06-27","time":"16:40:43","subject":"公告本公司114年股東常會重要決議事項","clause":"第18款","fact_date":"2025-06-27","cite_as":"公開資訊觀測站重大訊息：永鴻生技（6936），2025-06-27 16:40，「公告本公司114年股東常會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6876-2025-06-27-1639-arkidq","company_id":"6876","company":"朗齊生醫*","market":"興櫃","industry":"生技醫療","date":"2025-06-27","time":"16:39:51","subject":"公告本公司114年第一次現金增資收足股款暨增資基準日","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：朗齊生醫*（6876），2025-06-27 16:39，「公告本公司114年第一次現金增資收足股款暨增資基準日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7607-2025-06-27-1638-131v47z","company_id":"7607","company":"通用幹細胞*","market":"興櫃","industry":"生技醫療","date":"2025-06-27","time":"16:38:56","subject":"公告本公司114年第二次私募普通股收足股款暨增資基準日","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：通用幹細胞*（7607），2025-06-27 16:38，「公告本公司114年第二次私募普通股收足股款暨增資基準日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4174-2025-06-27-1637-1twflfh","company_id":"4174","company":"浩鼎","market":"上櫃","industry":"生技醫療","date":"2025-06-27","time":"16:37:23","subject":"公告本公司第一屆永續發展委員會委員","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：浩鼎（4174），2025-06-27 16:37，「公告本公司第一屆永續發展委員會委員」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4174-2025-06-27-1637-1uhzyg4","company_id":"4174","company":"浩鼎","market":"上櫃","industry":"生技醫療","date":"2025-06-27","time":"16:37:06","subject":"公告本公司第六屆薪資報酬暨提名委員會委員","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：浩鼎（4174），2025-06-27 16:37，「公告本公司第六屆薪資報酬暨提名委員會委員」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4174-2025-06-27-1636-x3r1zc","company_id":"4174","company":"浩鼎","market":"上櫃","industry":"生技醫療","date":"2025-06-27","time":"16:36:46","subject":"公告本公司第五屆審計暨風險管理委員會委員","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：浩鼎（4174），2025-06-27 16:36，「公告本公司第五屆審計暨風險管理委員會委員」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4174-2025-06-27-1636-tcvlos","company_id":"4174","company":"浩鼎","market":"上櫃","industry":"生技醫療","date":"2025-06-27","time":"16:36:26","subject":"本公司董事會推選梁賡義博士續任董事長","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：浩鼎（4174），2025-06-27 16:36，「本公司董事會推選梁賡義博士續任董事長」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6918-2025-06-27-1636-1ytifj","company_id":"6918","company":"愛派司","market":"上市","industry":"生技醫療","date":"2025-06-27","time":"16:36:25","subject":"本公司董事會通過轉投資讚賀生醫股份有限公司股權案","clause":"第20款","fact_date":"2025-06-27","cite_as":"公開資訊觀測站重大訊息：愛派司（6918），2025-06-27 16:36，「本公司董事會通過轉投資讚賀生醫股份有限公司股權案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6744-2025-06-27-1636-2bd6yl","company_id":"6744","company":"豐技生技","market":"興櫃","industry":"生技醫療","date":"2025-06-27","time":"16:36:10","subject":"公告本公司董事會委任第三屆薪資報酬委員會委員","clause":"第6款","fact_date":"2025-06-27","cite_as":"公開資訊觀測站重大訊息：豐技生技（6744），2025-06-27 16:36，「公告本公司董事會委任第三屆薪資報酬委員會委員」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4174-2025-06-27-1636-7dpt0l","company_id":"4174","company":"浩鼎","market":"上櫃","industry":"生技醫療","date":"2025-06-27","time":"16:36:03","subject":"本公司114年股東常會決議解除董事競業禁止限制","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：浩鼎（4174），2025-06-27 16:36，「本公司114年股東常會決議解除董事競業禁止限制」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4174-2025-06-27-1635-1kdh6a2","company_id":"4174","company":"浩鼎","market":"上櫃","industry":"生技醫療","date":"2025-06-27","time":"16:35:39","subject":"公告本公司114年股東常會改選董事當選名單","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：浩鼎（4174），2025-06-27 16:35，「公告本公司114年股東常會改選董事當選名單」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4174-2025-06-27-1635-ds864w","company_id":"4174","company":"浩鼎","market":"上櫃","industry":"生技醫療","date":"2025-06-27","time":"16:35:15","subject":"公告本公司114年股東常會重要決議事項","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：浩鼎（4174），2025-06-27 16:35，「公告本公司114年股東常會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7803-2025-06-27-1633-ds864w","company_id":"7803","company":"雲象科技-創","market":"上市","industry":"生技醫療","date":"2025-06-27","time":"16:33:37","subject":"公告本公司114年股東常會重要決議事項","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：雲象科技-創（7803），2025-06-27 16:33，「公告本公司114年股東常會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7607-2025-06-27-1628-8p66di","company_id":"7607","company":"通用幹細胞*","market":"興櫃","industry":"生技醫療","date":"2025-06-27","time":"16:28:27","subject":"公告本公司114年股東常會決議解除新任董事競業禁止限制案","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：通用幹細胞*（7607），2025-06-27 16:28，「公告本公司114年股東常會決議解除新任董事競業禁止限制案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-3164-2025-06-27-1626-1n50r1v","company_id":"3164","company":"景岳","market":"上市","industry":"生技醫療","date":"2025-06-27","time":"16:26:06","subject":"代重要子公司景岳生物枓技(中國)有限公司公告董事長異動","clause":"第6款","fact_date":"2024-06-21","cite_as":"公開資訊觀測站重大訊息：景岳（3164），2025-06-27 16:26，「代重要子公司景岳生物枓技(中國)有限公司公告董事長異動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-3164-2025-06-27-1625-10f20c6","company_id":"3164","company":"景岳","market":"上市","industry":"生技醫療","date":"2025-06-27","time":"16:25:44","subject":"代重要子公司景岳生物枓技(中國)有限公司公告總經理異動","clause":"第6款","fact_date":"2024-06-21","cite_as":"公開資訊觀測站重大訊息：景岳（3164），2025-06-27 16:25，「代重要子公司景岳生物枓技(中國)有限公司公告總經理異動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7607-2025-06-27-1623-5id246","company_id":"7607","company":"通用幹細胞*","market":"興櫃","industry":"生技醫療","date":"2025-06-27","time":"16:23:26","subject":"公告本公司114年股東常會全面改選董事(含獨立董事)當選名單暨董事變動達三分之一","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：通用幹細胞*（7607），2025-06-27 16:23，「公告本公司114年股東常會全面改選董事(含獨立董事)當選名單暨董事變動達三分之一」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7607-2025-06-27-1616-ds864w","company_id":"7607","company":"通用幹細胞*","market":"興櫃","industry":"生技醫療","date":"2025-06-27","time":"16:16:22","subject":"公告本公司114年股東常會重要決議事項","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：通用幹細胞*（7607），2025-06-27 16:16，「公告本公司114年股東常會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6939-2025-06-27-1613-1asmasq","company_id":"6939","company":"啟弘生技","market":"興櫃","industry":"生技醫療","date":"2025-06-27","time":"16:13:09","subject":"本公司114年股東常會重要決議事項","clause":"第15款","fact_date":"2025-06-27","cite_as":"公開資訊觀測站重大訊息：啟弘生技（6939），2025-06-27 16:13，「本公司114年股東常會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7827-2025-06-27-1542-54swv6","company_id":"7827","company":"漢康-KY創","market":"上市","industry":"生技醫療","date":"2025-06-27","time":"15:42:22","subject":"公告本公司法人董事改派代表人","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：漢康-KY創（7827），2025-06-27 15:42，「公告本公司法人董事改派代表人」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1781-2025-06-27-1512-18p9pdg","company_id":"1781","company":"合世","market":"上櫃","industry":"生技醫療","date":"2025-06-27","time":"15:12:34","subject":"公告更補正本公司113年度合併財報、113年度個體財報以及114年第1季合併財報部分內容誤植","clause":"第53款","fact_date":"2025-06-27","cite_as":"公開資訊觀測站重大訊息：合世（1781），2025-06-27 15:12，「公告更補正本公司113年度合併財報、113年度個體財報以及114年第1季合併財報部分內容誤植」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6637-2025-06-27-1509-ds864w","company_id":"6637","company":"醫影","market":"上櫃","industry":"生技醫療","date":"2025-06-27","time":"15:09:20","subject":"公告本公司114年股東常會重要決議事項","clause":"第18款","fact_date":"2025-06-27","cite_as":"公開資訊觀測站重大訊息：醫影（6637），2025-06-27 15:09，「公告本公司114年股東常會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1781-2025-06-27-1505-cs783i","company_id":"1781","company":"合世","market":"上櫃","industry":"生技醫療","date":"2025-06-27","time":"15:05:45","subject":"更正114/03/13本公司董事會決議增資子公司之公告","clause":"第53款","fact_date":"2025-03-13","cite_as":"公開資訊觀測站重大訊息：合世（1781），2025-06-27 15:05，「更正114/03/13本公司董事會決議增資子公司之公告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4726-2025-06-27-1501-1rphmbj","company_id":"4726","company":"永昕","market":"上櫃","industry":"生技醫療","date":"2025-06-27","time":"15:01:51","subject":"本公司受邀參加元富證券法人說明會","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：永昕（4726），2025-06-27 15:01，「本公司受邀參加元富證券法人說明會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7729-2025-06-27-1458-ds864w","company_id":"7729","company":"仲恩生醫","market":"興櫃","industry":"生技醫療","date":"2025-06-27","time":"14:58:39","subject":"公告本公司114年股東常會重要決議事項","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：仲恩生醫（7729），2025-06-27 14:58，「公告本公司114年股東常會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6541-2025-06-27-1437-1bkm0mx","company_id":"6541","company":"泰福-KY","market":"上市","industry":"生技醫療","date":"2025-06-27","time":"14:37:54","subject":"公告本公司代理發言人異動","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：泰福-KY（6541），2025-06-27 14:37，「公告本公司代理發言人異動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6541-2025-06-27-1437-1vjburh","company_id":"6541","company":"泰福-KY","market":"上市","industry":"生技醫療","date":"2025-06-27","time":"14:37:33","subject":"公告本公司變更在台訴訟及非訟代理人聯絡資訊","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：泰福-KY（6541），2025-06-27 14:37，「公告本公司變更在台訴訟及非訟代理人聯絡資訊」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6541-2025-06-27-1436-5vl08h","company_id":"6541","company":"泰福-KY","market":"上市","industry":"生技醫療","date":"2025-06-27","time":"14:36:56","subject":"公告本公司訴訟及非訟代理人異動","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：泰福-KY（6541），2025-06-27 14:36，「公告本公司訴訟及非訟代理人異動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6541-2025-06-27-1436-1vhu1xi","company_id":"6541","company":"泰福-KY","market":"上市","industry":"生技醫療","date":"2025-06-27","time":"14:36:04","subject":"公告本公司發言人異動","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：泰福-KY（6541），2025-06-27 14:36，「公告本公司發言人異動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6814-2025-06-27-1344-179sgxo","company_id":"6814","company":"路迦生醫","market":"興櫃","industry":"生技醫療","date":"2025-06-27","time":"13:44:04","subject":"本公司受邀參加元富證券舉辦「2025年美容保健生技產業研討會」","clause":"第30款","fact_date":"2025-06-27","cite_as":"公開資訊觀測站重大訊息：路迦生醫（6814），2025-06-27 13:44，「本公司受邀參加元富證券舉辦「2025年美容保健生技產業研討會」」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6976-2025-06-27-1328-ds864w","company_id":"6976","company":"育世博-KY","market":"興櫃","industry":"生技醫療","date":"2025-06-27","time":"13:28:29","subject":"公告本公司114年股東常會重要決議事項","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：育世博-KY（6976），2025-06-27 13:28，「公告本公司114年股東常會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6814-2025-06-27-0856-1pzjlpi","company_id":"6814","company":"路迦生醫","market":"興櫃","industry":"生技醫療","date":"2025-06-27","time":"08:56:34","subject":"公告本公司預估未來三個月現金收支情形及銀行可使用融資額度情形","clause":"第44款","fact_date":"2025-06-27","cite_as":"公開資訊觀測站重大訊息：路迦生醫（6814），2025-06-27 08:56，「公告本公司預估未來三個月現金收支情形及銀行可使用融資額度情形」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"}]}